Tradition Wealth Management’s TG Therapeutics TGTX Stock Holding History

Tradition Wealth Management’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$222K	Buy	+6,681	New	+$199K	0.02%	454
2025 Q4	–	Sell	-6,066	Closed	-$219K	–	513
2025 Q3	$219K	Buy	6,066 +360	+6%	+$11.9K	0.02%	441
2025 Q2	$205K	Sell	5,706 -252	-4%	-$9.38K	0.02%	424
2025 Q1	$235K	Buy	+5,958	New	+$200K	0.02%	386
2024 Q1	–	Sell	-5,958	Closed	-$102K	–	1106
2023 Q4	$102K	Hold	5,958	–	–	0.01%	469
2023 Q3	$50K	Hold	5,958	–	–	0.01%	606
2023 Q2	$148K	Sell	5,958 -2,285	-28%	-$59K	0.02%	364
2023 Q1	$124K	Buy	8,243 +1,785	+28%	+$27.1K	0.02%	387
2022 Q4	$76K	Hold	6,458	–	–	0.01%	436
2022 Q3	$38K	Hold	6,458	–	–	0.01%	591
2022 Q2	$27K	Sell	6,458 -439	-6%	-$2.74K	﹤0.01%	593
2022 Q1	$66K	Buy	6,897 +821	+14%	+$9.5K	0.01%	452
2021 Q4	$115K	Buy	6,076 +1,130	+23%	+$29.3K	0.01%	380
2021 Q3	$165K	Buy	4,946 +410	+9%	+$12.7K	0.02%	299
2021 Q2	$176K	Hold	4,536	–	–	0.03%	304
2021 Q1	$219K	Hold	4,536	–	–	0.04%	240
2020 Q4	$236K	Buy	+4,536	New	+$153K	0.05%	215

Other funds holding TGTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Tradition Wealth Management's TGTX Position: Q1 2026 in Review

Tradition Wealth Management opened a new position in TG Therapeutics (TGTX) in Q1 2026: 6,681 shares worth $222K. The stake represents 0.02% of the portfolio and ranks #454 among its holdings. This is a return to the name: Tradition Wealth Management previously reported a position in TGTX as recently as Q3 2025.

Tradition Wealth Management first reported a position in TGTX in Q4 2020 and has held it in 17 quarters since. The position peaked at $236K in Q4 2020. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

Tradition Wealth Management held 6,681 shares of TG Therapeutics worth $222K as of Q1 2026.
TG Therapeutics was a new Tradition Wealth Management position in Q1 2026.
TG Therapeutics made up 0.02% of Tradition Wealth Management's portfolio in Q1 2026, its #454 holding.
Tradition Wealth Management first reported a position in TG Therapeutics in Q4 2020 and has held it in 17 quarters since.
Tradition Wealth Management's TG Therapeutics position peaked at $236K in Q4 2020.
363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Tradition Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.